| Interim considerations for COVID-19 vaccination of healthcare personnel and long-term care facility residents | Centers for Disease Control and Prevention |
|---|---|
| Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations | Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with the U |
FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine.
| Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
|---|---|
| Centers for Disease Control and Prevention | Benefits of getting a COVID-19 vaccine |
Centers for Disease Control and Prevention.
10| Vaccination considerations for persons with underlying medication conditions | What to expect after getting a COVID-19 vaccine |
|---|---|
| Janssen COVID-19 vaccine: Fact sheet for healthcare providers administering vaccine | Interim public health recommendations for vaccinated people |
Pfizer-BioNTech vaccine: Fact sheet for recipients and caregivers.